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Abstract
Synaptic activity can boost neuroprotection through a mechanism that requires synapse-to-nucleus communication and
calcium signals in the cell nucleus. Here we show that in hippocampal neurons nuclear calcium is one of the most potent
signals in neuronal gene expression. The induction or repression of 185 neuronal activity-regulated genes is dependent
upon nuclear calcium signaling. The nuclear calcium-regulated gene pool contains a genomic program that mediates
synaptic activity-induced, acquired neuroprotection. The core set of neuroprotective genes consists of 9 principal
components, termed Activity-regulated Inhibitor of Death (AID) genes, and includes Atf3, Btg2, GADD45b, GADD45c, Inhibin b-
A, Interferon activated gene 202B, Npas4, Nr4a1, and Serpinb2, which strongly promote survival of cultured hippocampal
neurons. Several AID genes provide neuroprotection through a common process that renders mitochondria more resistant
to cellular stress and toxic insults. Stereotaxic delivery of AID gene-expressing recombinant adeno-associated viruses to the
hippocampus confers protection in vivo against seizure-induced brain damage. Thus, treatments that enhance nuclear
calcium signaling or supplement AID genes represent novel therapies to combat neurodegenerative conditions and
neuronal cell loss caused by synaptic dysfunction, which may be accompanied by a deregulation of calcium signal initiation
and/or propagation to the cell nucleus.
Citation: Zhang S-J, Zou M, Lu L, Lau D, Ditzel DAW, et al. (2009) Nuclear Calcium Signaling Controls Expression of a Large Gene Pool: Identification of a Gene
Program for Acquired Neuroprotection Induced by Synaptic Activity. PLoS Genet 5(8): e1000604. doi:10.1371/journal.pgen.1000604
Editor: Harry Orr, University of Minnesota, United States of America
Received December 23, 2008; Accepted July 16, 2009; Published August 14, 2009
Copyright:  2009 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Alexander von Humboldt-Foundation (Wolgang-Paul-Prize to H.B.), the Deutsche Forschungsgemeinschaft (DFG), the
SFB488 of the DFG, the EU Network of Excellence NeuroNE, and the EU Project GRIPANNT. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Hilmar.Bading@uni-hd.de
¤a Current address: Kavli Institute for Systems Neuroscience, Centre for the Biology of Memory, Norwegian University of Science and Technology, Trondheim,
Norway
¤b Current address: Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
¤c Current address: Max Planck Institute of Neurobiology, Mu ¨nchen, Germany
Introduction
Physiologicallevelsofsynapticactivityarerequiredforneuronsto
survive [1]. Activity-dependent neuroprotection is induced by
calcium entry through synaptic NMDA receptors and requires that
calcium transients invade the cell nucleus [2–6]. Procedures that
interfere with electrical activity and compromise NMDA receptor
function or nuclear calcium signaling canhavedeleteriouseffects on
the health of neurons both in vitro and in vivo. For example, blockade
of NMDA receptors in vivo following intraperitoneal injections of the
NMDA receptor antagonist MK-801 into seven day-old rats
triggers, within 24 hours, a wave of apoptotic neurodegeneration
in many brain regions, including the parietal and frontal cortex, the
thalamus and the hippocampus [7]. Likewise, the selective blockade
of nuclear calcium signaling prevents cultured hippocampal
neurons from building up anti-apoptotic activity upon synaptic
NMDA receptor stimulation [2,3,6]. Conversely, enhancing
neuronal firing and synaptic NMDA receptor activity is neuropro-
tective: networks of cultured hippocampal neurons that have
experienced periods of action potential bursting causing calcium
entry through synaptic NMDA receptors are more resistant to cell
death-inducing conditions [2–4]. Moreover, stimulating synaptic
activity in vivo by exposing rats to enriched environments reduces
spontaneous apoptotic cell death in the hippocampus and protects
against neurotoxic injuries [8].
Neuronal activity and NMDA receptor-induced calcium
signaling pathways can suppress apoptosis and promote survival
through two mechanistically distinct processes. One process is
independent of on-going gene transcription and involves the
phosphatidylinositide 39-OH kinase (PI3K)-AKT signaling path-
way which promotes survival while neurons are being electrically
stimulated [3]. However, the principal pathway conferring long-
lasting neuroprotection requires the generation of calcium
transients in the cell nucleus [2–6,9]. The aim of this study was
to investigate how nuclear calcium promotes neuroprotection.
Using tools to selectively block nuclear calcium signaling in
hippocampal neurons in conjunction with microarray technologies
and bioinformatics, we uncovered a genomic survival program
that is induced by calcium transients in the cell nucleus. The core
PLoS Genetics | www.plosgenetics.org 1 August 2009 | Volume 5 | Issue 8 | e1000604components of this program, referred to as Activity-regulated Inhibitor
of Death (AID) genes, can provide neurons with a broad-spectrum
neuroprotective shield against cell death.
Results
Identification of nuclear calcium–regulated genes
To identify genes regulated by nuclear calcium signaling in
hippocampal neurons, we carried out comparative whole-genome
transcriptional profiling. Hippocampal neurons were infected with
a recombinant adeno-associated virus (rAAV) expressing either the
calmodulin (CaM) binding-peptide, CaMBP4 (rAAV-CaMBP4 [6])
or b-galactosidase (rAAV-LacZ) as a control. CaMBP4 is a nuclear
protein that contains 4 repeats of the M13 calmodulin binding
peptide derived from the rabbit skeletal muscle myosin light chain
kinase; it binds to and inactivates the nuclear calcium/CaM
complex [10]. Inhibition of nuclear calcium signaling with
CaMBP4 in hippocampal neurons blocks synaptic activity-evoked
CREB-mediated transcription and prevents the induction of a
genomic neuroprotective program by neuronal activity [3,6].
Hippocampal neurons were stimulated by exposing the network to
the GABAA receptor antagonist, bicuculline. GABAergic inter-
neurons, which represent about 11% of the neuron population,
impose a tonic inhibition onto the network [11]. Removal of
GABAAergic inhibition with bicuculline leads to action potential
(AP) bursting, which stimulates calcium entry though synaptic
NMDA receptors, generates robust cytoplasmic and nuclear
calcium transients, induces CREB-dependent transcription, and
strongly promotes neuronal survival [2–4,6,11,12]. RNA isolated
from these hippocampal neurons was used for microarray analyses
on Affymetrix GeneChips. The Affymetrix microarray data were
analyzed by a two-step process; details of the data analysis are
described in Text S1. First, we determined all genes induced or
repressed by AP bursting (which gives rise to robust nuclear
calcium signals) in control-infected (rAAV-LacZ) hippocampal
neurons. A threshold of 2.0 fold was chosen, which, given that
microarray data are compressed and generally underestimates the
fold differences in gene expression [6,13], filters out genes that are
likely to undergo signal-induced changes in their expression that
are in the range of at least 2.5 to 3 fold. This analysis revealed 302
genes that were induced and 129 genes that were repressed in
rAAV-LacZ infected hippocampal neurons 4 hours after the
induction of AP bursting. A color-coded map provides an overview
of these 431 AP bursting-regulated genes (Figure 1A). A
comparison of the genes identified in this study using rAAV-LacZ
infected hippocampal neurons with the pool of activity-regulated
genes described in a previous study [6] revealed a high degree of
overlap. However, due to the higher threshold applied in this
analysis (2 fold vs. 1.5 fold change used in our previous study [6]),
the current analysis filtered out fewer genes.
In a second analysis step, we compared the expression of genes
regulated by AP bursting in hippocampal neurons infected with
rAAV-LacZ and in hippocampal neurons infected with rAAV-
CaMBP4 to block the nuclear calcium/CaM complex. The
regulation of a gene was considered dependent on nuclear calcium
signaling if based on the microarray data its induction or repression
by AP bursting is reduced by at least 40% in rAAV-CaMBP4
infected neurons compared to rAAV-LacZ infected neurons. We
found that 183 genes (plus Btg2 and Bcl6; see below) fulfill these
criteria (Figure 1B); a list of those genes including their fold changes
followingAPburstingand percent inhibitionbyCaMBP4 isgivenin
Table 1. We are likely to underestimate the total number of genes
regulated by nuclear calcium signaling for several reasons. First, our
screen did not identify genes controlled by the downstream
regulatory element antagonist modulator (DREAM) [14]. DREAM
is a transcriptional repressor that can directly bind calcium through
its EF hands. In its calcium-bound form, DREAM is released from
the DNA allowing transcription to be activated in a nuclear
calcium-dependent but calmodulin-independent manner [14].
Second, our analysis was restricted to one time point (i.e. 4 hours
after induction of AP bursting) and therefore it is possible that we
have missed genes that have peak expression levels at time points
significantly earlier or later than 4 hours. Although those genes may
also show changes in expression levels at 4 hours after AP bursting,
if this induction was less than two fold they were not scored as
induced in our study. Third, a possible regulation by nuclear
calcium could also have been missed because for genes weakly
induced by AP bursting, the accuracy of the microarray data–based
assessment of nuclear calcium regulation decreases and the
necessary statistical criteria may not be met. Indeed, these
conditions apply to two neuronal survival-promoting genes, Btg2
and Bcl6 [6]. Btg2 is induced with fast kinetics after AP bursting; the
induction peaks at 2 hours [about 8 fold induction based on
microarray data and 17 foldinduction based on quantitative reverse
transcriptase (QRT)-PCR analysis [6]], whereas at the 4 hours time
point the change in expression based on microarray data relative to
unstimulated control is only about 2 fold [6]. In the case of Bcl6,t h e
fold changes observed at 4 hours after the on-set of AP bursting are
about 1.5 fold based on microarray data analysis and about 2.5 fold
based on QRT-PCR analysis [6]. Both, Btg2 and Bcl6, are regulated
by nuclear calcium signaling [6] and have therefore been included
in the list of nuclear calcium-regulated genes (Table 1). The
identified nuclear calcium-regulated gene pool comprises 43% of all
activity-regulated genes. It contains a large variety of gene products
with different catalytic and binding activities (Figure 1C).
Nuclear calcium–regulated survival genes
Because nuclear calcium signals evoked by AP bursting strongly
promote neuronal survival [2–4,6], we next aimed at identi-
fying putative neuroprotective genes present in the nuclear
Author Summary
The dialogue between the synapse and the nucleus plays
an important role in the physiology of neurons because it
links brief changes in the membrane potential to the
transcriptional regulation of genes critical for neuronal
survival and long-term memory. The propagation of
activity-induced calcium signals to the cell nucleus
represents a major route for synapse-to-nucleus commu-
nication. Here we identified nuclear calcium-regulated
genes that are responsible for a neuroprotective shield
that neurons build up upon synaptic activity. We found
that among the 185 genes controlled by nuclear calcium
signaling, a set of 9 genes had strong survival promoting
activity both in cell culture and in an animal model of
neurodegeneration. The mechanism through which sever-
al genes prevent cell death involves the strengthening of
mitochondria against cellular stress and toxic insults. The
discovery of an activity-induced neuroprotective gene
program suggest that impairments of synaptic activity and
synapse-to-nucleus signaling, for example due to expres-
sion of Alzheimer’s disease protein or in aging, may
comprise the cells’ own neuroprotective system eventually
leading to cell death. Thus, malfunctioning of nuclear
calcium signaling could be a key etiological factor
common to many neuropathological conditions, providing
a simple and unifying concept to explain disease- and
aging-related cell loss.
Nuclear Calcium in Acquired Neuroprotection
PLoS Genetics | www.plosgenetics.org 2 August 2009 | Volume 5 | Issue 8 | e1000604Figure 1. Color-coded map of genes regulated by neuronal activity and nuclear calcium signaling and their molecular functions.
Each box corresponds to one gene whose position within the two maps is identical; corresponding positions on the map indicate the regulation of a
given gene by AP bursting and nuclear calcium signaling. (A) The maximum fold change in expression (induction or repression) based on Affymetrix
microarray analysis at 4 hours after the on-set of action potential (AP) bursting is color-coded as indicated. Genes are sorted on the basis of their
induction/repression values in a ‘‘descending’’ order, i.e. from the highest levels of induction following AP bursting at the top (indicated in dark red
color) to the highest level of repression following AP bursting at the bottom (indicated in dark green color). (B) Genes whose induction or repression
by AP bursting is inhibited by expression of CaMBP4 are highlighted in blue; more than 80% inhibition (dark blue), between 60 and 80% inhibition
(light blue), between 40 and 60% inhibition (very light blue). White boxes indicate genes whose induction or repression by AP bursting is inhibited
less than 40% by expression of CaMBP4. The complete list of all blue-indicated genes is given in Table 1. (C) Molecular functions of the 185 nuclear
calcium-regulated genes based on Gene Ontology information provided by Affymetrix (http://www.affymetrix.com).
doi:10.1371/journal.pgen.1000604.g001
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analysis with the GO term ‘Apoptosis’ and a literature search
we were able to identify 20 nuclear calcium-regulated genes that
have been implicated in cell death/survival processes in non-
neuronal or neuronal cells (Table 1). Our attention was drawn in
particular to 8 nuclear calcium-regulated genes that, based on the
microarray data, showed a very robust induction (more than 10
fold changes) of expression following neuronal activity. This
includes 6 genes with known or putative functions in the cell
nucleus (Atf3, GADD45b, GADD45c, Interferon activated gene 202b
(Ifi202b), Npas4, and Nr4a1) and 2 genes encoding secreted proteins
(Inhibin b-A and Serpinb2). Atf3 (activating transcription factor 3) is a
member of the ATF/cAMP-responsive element-binding protein
(CREB) family of transcription factors [15] that has been
implicated in survival processes in neuronal and non-neuronal
cells [16–18]. The family of growth arrest and DNA damage-
inducible 45 (GADD45) genes comprises three members
(GADD45a, GADD45b and GADD45c) that are expressed in
response to stress stimuli and DNA damage. GADD45 genes have
been implicated in DNA excision-repair processes [19,20] but may
also contribute to gene transcription via a process that involves
DNA demethylation [21]. Ifi202b belongs to the interferon-
activated p202 gene family that plays a role in cell survival and the
regulation of caspase activation [22,23]. Npas4 (also known as NxF)
is a member of the basic helix-loop-helix/Per-Arnt-Sim (bHLH-
PAS) homology protein family [24]; it functions as a transcrip-
tional regulator with possible roles in cell survival and differen-
tiation [25,26]. Nr4a1 (also known as nur77 or NGFIB) is an orphan
nuclear hormone receptor with possible pro-apoptotic and anti-
apoptotic functions [27–29]. Serpinb2 [also known as plasminogen
activator inhibitor type-2 (PAI-2)] is a serine proteinase inhibitor
that can influence cell proliferation, differentiation and cell death
[30,31]. Inhibin b-A is a member of the transforming growth factor
(TGF)-b superfamily [32] that can protect human SH-SY5Y
neuroblastoma cells from chemical-induced death and may
mediate neuroprotective actions of basic FGF [33,34]. We
considered these 8 genes plus the previously identified pro-survival
gene Btg2 (which is robustly induced by neuronal activity in a
nuclear calcium-dependent manner [6]) as the core components of
the putative neuroprotective gene program and refer to this set of
genes hereafter as Activity-regulated Inhibitor of Death (AID) genes
(Table 1; AID genes are boxed).
Using QRT-PCR, we confirmed the regulation of each AID
gene by AP bursting and nuclear calcium signaling; the regulation
of Btg2 by nuclear calcium signaling has been established
previously [6]. The expression of GADD45b, GADD4c, and
Nr4a1 increased about 20 to 35 fold after AP bursting, which
were the weakest inductions among this group of genes (Figure 2).
Significantly higher fold changes relative to unstimulated control
in either uninfected or rAAV-LacZ infected hippocampal neurons
were observed for Atf3 (6364 fold, uninfected; 4964 fold, rAAV-
LacZ), Npas4 (203617 fold, uninfected; 18669 fold, rAAV-LacZ),
Ifi202b (288619 fold, uninfected; 246630 fold, rAAV-LacZ), and
Inhibin b-A (432641 fold, uninfected; 388630 fold, rAAV-LacZ)
(Figure 2). For Serpinb2, QRT-PCR revealed a very dramatic,
1839645 fold increase in expression following AP bursting in
uninfected hippocampal neurons and 1781648 fold increase in
rAAV-LacZ infected hippocampal neurons (Figure 2). This is - to
the best of our knowledge - the highest fold change ever observed
for a signal–regulated gene. For all AID genes, we confirmed the
requirement for nuclear calcium signaling for their induction by
AP bursting (Figure 2). Most dramatic inhibitions of well over 80
percent were observed for Inhibin b-A (9363% inhibition), Npas4
(9263% inhibition), Ifi202b (8764% inhibition), and Serpinb2
(8563% inhibition), and Atf3 (8065%) (Figure 2). We also
included prostaglandin-endoperoxide synthase 2 (Ptgs2; also
known as Cox2) in the QRT-PCR analysis. Expression of Ptgs2 is
robustly induced by neuronal activity (80624 fold, uninfected;
78618 fold, rAAV-LacZ), and this induction was inhibited by
CaMBP4 by 68620% (Figure 2). Because there is no available
evidence for a role of Ptgs2 in promoting survival of neuronal or
non-neuronal cells, this gene served as one of the negative controls
in the in vivo survival experiments (see below).
Given the importance of CREB and its co-activator CREB
binding protein (CBP) in mediating transcriptional activation by
synaptic activity and nuclear calcium signaling [12,35,36] and the
critical role of CREB in neuronal survival [3,37,38], we carried
out data base searches to determine whether the nuclear calcium-
regulated genes, in particular AID genes, contain putative CREB
binding sites. Information retrieved from two databases (the
CREB ‘regulon’ (http://saco.ohsu.edu/) [39] and the CREB
target gene database (http://natural.salk.edu/creb/) [40] indicat-
ed that a large fraction of the nuclear calcium regulated gene pool
(56%) and all AID genes except Npas4 contain one or several CREs
or CRE-like sequences, suggesting that they could be CREB target
genes (Table S1). In addition to CREB, other CBP-recruiting
transcription factors may contribute to the regulation of AID genes
by nuclear calcium signaling.
We next investigated the role of the nuclear calcium/
calmodulin-dependent protein kinase IV (CaMKIV) in the
regulation of AID genes. CaMKIV is one important mediator of
nuclear calcium/CREB-regulated transcription [36,41–46]. To
inhibit CaMKIV activity, we infected hippocampal neurons with a
rAAV containing an expression cassette for a kinase-inactive form
of CaMKIV (CaMKIVK75E) that functions as a negative
interfering mutant of CaMKIV [36,42,43]; immunoblot analysis
of expression of CaMKIVK75E in hippocampal neurons infected
with rAAV-CaMKIVK75E is shown in Figure 3A. We found that
in hippocampal neurons infected with rAAV-CaMKIVK75E the
induction by AP bursting of all AID genes and induction of Ptgs2
was inhibited (Figure 2). For 5 AID genes (i.e. GADD45b,
GADD45c, Serpinb2, Inhibin b-A, and Ifi202b) and for Ptgs2, the
percent inhibition by rAAV-CaMKIVK75E was very similar to the
inhibition obtained by the blockade of nuclear calcium signaling
using CaMBP4 (Figure 2). CaMKIVK75E was slightly less potent
than CaMBP4 in inhibiting induction of Atf3, Npas4, and Nr4a1
(Figure 2), suggesting that targets of nuclear calcium other than
CaMKIV may contribute to regulation of these genes by neuronal
activity. These results indicate that nuclear calcium-CaMKIV is
an important regulatory module of AID genes.
AID genes promote neuronal survival in vitro
We next investigated the role of AID genes in neuronal survival.
We first carried out gain-of-function experiments in which we used
rAAV-mediated gene delivery to over-express Flag-tagged AID
proteins in cultured hippocampal neurons. Expression of the
proteins was assessed with immunoblots using antibodies to the
Flag-tag (Figure 3A). Infection rates were determined immunocy-
tochemically and ranged from 80 to 95 percent of the viable
neurons (data not shown). We used two types of assays to assess
apoptotic cell death: growth factor withdrawal and treatment of
cultured hippocampal neurons with a low concentration of
staurosporine [2,6], a classical inducer of apoptotic cell death.
We found that compared to control (i.e. non-infected neurons or
neurons infected with rAAV-LacZ), cell death induced by either
growth factor withdrawal or staurosporine treatment was inhibited
in neurons infected with rAAV carrying Flag-tagged AID proteins
(Figure 3B). Inhibition of apoptosis ranged from about 30 to 95%
Nuclear Calcium in Acquired Neuroprotection
PLoS Genetics | www.plosgenetics.org 6 August 2009 | Volume 5 | Issue 8 | e1000604for growth factor withdrawal-induced apoptosis and from about 40
to 80% for apoptosis induced by staurosporine (Figure 3B). Over-
expression of Atf3, Nr4a1, GADD45b, and GADD45c yielded the
most potent inhibition for growth factor withdrawal-induced
apoptosis, whereas expression of Npas4 was most efficient in
protecting against staurosporine-induced apoptosis (Figure 3B).
These results indicate that AID proteins can confer robust
neuroprotection to cultured hippocampal neurons.
We next investigated whether AID genes contribute to activity-
dependent survival induced by AP bursting and activation of
synaptic NMDA receptors [2–4,6]. For this analysis, we selected
three genes (Atf3, GADD45b,a n dGADD45c) that protected
efficiently against growth factor withdrawal-induced apoptosis and
Npas4 that protected efficiently against staurosporine induced
apoptosis (see Figure 3B). RNA interference (RNAi) was used to
inhibit expression of these genes following synaptic activity. DNA
sequences encoding short hairpin RNAs (shRNAs) designed to
appropriate target regions were inserted downstream of the U6
promoter of a rAAV vector that also harbors an expression cassette
for humanized Renilla reniformis green fluorescent protein (hrGFP)
[6] (for details see Text S1). To control for non-specific effects of
infectionswithrAAVscarryinganexpression cassetteforshRNAs, a
rAAV was used that contains a universal control shRNA (rAAV-
Control-RNAi), which has no significant sequence similarity to the
mouse, rat, or human genome. For all rAAVs carrying an
expression cassette for shRNAs, infection rates of 80 to 95 percent
of the neuron population were obtained (data not shown). QRT-
PCR analysis revealed that RNAi was effective in eliminating
induction of Atf3, GADD45b,a n dGADD45c, and Npas4 by AP
bursting in hippocampal neurons. The inhibition of expression was
in the range of 85% for all 4 genes; rAAV-Control-RNAi had no
significant effect (Figure 4A). Given the neurotropism of rAAVs
used in the study [47], the results also indicate that the induction of
these genes occurs in hippocampal neurons and not in glial cells.
To assess activity-dependent survival, apoptotic cells were
counted after treatment with staurosporine or withdrawal of growth
factors with and without previous periods of neuronal activity
(Figure 4B and 4C) [2,3,6]. In the staurosporine assays, we detected
about 10 to 15% of apoptotic cells in the control condition, which
increased to about 60% after treatment (Figure 4B). In the growth
factor withdrawal assays, basal cell death was slightly higher (about
20 to 25%) and also increased to about 60% (Figure 4C). Upon
subjecting the neurons to a period of 12–16 hours of synaptic
activity (induced by bicuculline treatment in the presence of 4-
amino pyridine, which increases the burst frequency [2]) prior to
growth factor withdrawal or staurosporine exposure, far fewer cells
Figure 2. Nuclear calcium signaling controls activity-dependent regulation of AID genes. Affymetrix GeneChip profiles and QRT-PCR
analysis of the indicated AID genes and Ptgs2 are shown. Uninfected hippocampal neurons or hippocampal neurons infected with rAAV-LacZ, rAAV-
CaMBP4, or rAAV-CaMKIVK75E were left unstimulated or were stimulated for 4 hours with 50 mM bicuculline (to induce AP bursting). Total RNA
extracted from hippocampal neurons was used for GeneChip expression profiling and QRT–PCR analysis. Bars represent means6SEM (GeneChip,
n=3; QRT–PCR, n=4). Statistical analysis of the inhibition of the AP bursting-induced increase in mRNA expression, assessed using QRT-PCR, by
CaMBP4 or CaMKIVK75E relative to rAAV-LacZ control was determined by analysis of variance (ANOVA); *p,0.05; **p,0.01; ***p,0.001. The
significance of the AP bursting-induced increase in expression (compared to unstimulated control), assessed using QRT–PCR, in uninfected
hippocampal neurons and in hippocampal neurons infected with rAAV-LacZ was p,0.001 for each gene shown.
doi:10.1371/journal.pgen.1000604.g002
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activity-dependent survival is triggered by calcium entry into the
neurons through synaptic NMDA receptors and involves nuclear
calcium signaling [2–4,6]. In uninfected neurons and neurons
infected with rAAV-Control-RNAi, we observed the typical
stimulus-induced increase in apoptotic cells; following the period
of synaptic activity prior to staurosporine exposure or growth factor
withdrawal, the stimulus-induced cell death was reduced (Figure 4B
and 4C). In contrast, in neurons infected with rAAV-Atf3-RNAi,
rAAV-GADD45b-RNAi, rAAV-GADD45c-RNAi, and rAAV-
Npas4-RNAi the basal level of cell death was slightly elevated and
activity-dependent survival was severely compromised (Figure 4B
Figure 3. AID genes promote neuronal survival in vitro. (A) Immunoblot analysis of viral vector mediated genes expression in hippocampal
neurons. Hippocampal neurons were infected with rAAV-Empty, rAAV-LacZ, rAAV-CaMBP4, rAAV-CaMKIVK75E, rAAV-Npas4, rAAV-Nr4a1, rAAV-Atf3,
rAAV-Ifi202b, rAAV-GADD45b, rAAV-GADD45c, rAAV-Inhba, rAAV-Serpinb2, rAAV-Ptgs2, or rAAV-Btg2 and Flag-tagged proteins were detected with
anti-Flag antibodies. (B) Analysis of cell death induced by growth factor withdrawal or staurosporine treatment in hippocampal neurons infected with
rAAVs expressing Atf3, GADD45b, GADD45c, Ifi202b, Inhibin b-A, LacZ, Npas4, Nr4a1, and Serpinb2. The growth factor withdrawal- and
staurosporine-induced increase in dead cells in infected neurons relative to the growth factor withdrawal- and staurosporine-induced increase in
dead cells in uninfected neurons was calculated; the effects of viral vector-mediated expression of the indicated genes is shown as percentage
inhibition of cell death relative to uninfected control. Bars represent means6SEM (n=3). Statistical analysis was determined by analysis of variance
(ANOVA); **p,0.01; ***p,0.001.
doi:10.1371/journal.pgen.1000604.g003
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dependent induction of Npas4, Atf3, GADD45b and GADD45c using RNAi. Uninfected hippocampal neurons or hippocampal neurons infected with
rAAVs expressing either a control shRNA (rAAV-Control-RNAi) or shRNAs that target Atf3 (rAAV-Atf3-RNAi), GADD45b (rAAV-GADD45b-RNAi), GADD45c
(rAAV-GADD45c-RNAi), or Npas4 (rAAV-Npas4-RNAi) were stimulated for 4 hours with 50 mM bicuculline to induce AP bursting or were left
unstimulated. Bars represent means6SEM (n=3). Statistical analysis was determined by analysis of variance (ANOVA); ***p,0.001. For each gene
shown, the significance for the AP bursting-induced increase in expression (compared to unstimulated control), in uninfected hippocampal neurons
and in hippocampal neurons infected with rAAV-Control-RNAi was p,0.001 (ANOVA). (B,C) Analysis of the role of Atf3, GADD45b, GADD45c and Npas4
in activity-dependent neuronal survival. Uninfected hippocampal neurons or hippocampal neurons infected with rAAV-Control-RNAi, rAAV-Atf3-RNAi,
rAAV-GADD4b-RNAi, rAAV-GADD45c-RNAi and rAAV-Npas4-RNAi were left untreated or were treated for 16 hours with bicuculline (50 mM) in the
presence of 4-AP (250 mM) to induce activity-dependent neuronal survival. Subsequently, apoptosis induced by staurosporine treatment (B) or
growth factor withdrawal (-GF) (C) was analyzed. Expression of rAAV-Atf3-RNAi, rAAV-GADD45b-RNAi, rAAV-GADD45c-RNAi or rAAV-Npas4-RNAi but
not rAAV-Control-RNAi reduced neuroprotection afforded by synaptic activity. Bars represent means6SEM (B, n=3;C,n=3). Statistical analysis was
determined by analysis of variance (ANOVA); ***p,0.001; N.S, not significant. The infection rates ranged from 85 to 95 percent of the neurons; they
were determined immunocytochemically using antibodies to hrGFP or by analyzing the fluorescence of hrGFP. In both types of cell death assays, the
basal cell death rates in hippocampal neurons expressing shRNAs specific for Atf3, Npas4, GADD4b,o rGADD45c were higher than the basal death
rates obtained in hippocampal neurons expressing the control shRNA; for both cell death assays, p,0.01 for Npas4, GADD45b,o rGADD45c and
p,0.001 for Atf3.
doi:10.1371/journal.pgen.1000604.g004
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GADD45c and Npas4 are important for neuronal survival and
represent key components of the synaptic NMDA receptor-induced
genomic neuroprotective program.
Neuroprotection through inhibition of death signal–
induced mitochondrial permeability transition
Virtually all cell death processes involve the deregulation of
mitochondrial functions. One important early event in excitotoxic
cell death is the collapse of the mitochondria membrane potential
and the shift in the mitochondrial membrane permeability, known
as mitochondrial permeability transition (MPT) [48–50]. Using
Rhodamine 123 (Rh123) imaging techniques to monitor the
mitochondrial membrane potential, we have recently shown that
one mechanism through which down-regulation of the tumor
suppressor gene, p53, or increasing expression of Btg2 can
enhance the survival of hippocampal neurons involves inhibition
of the NMDA-induced break-down of the mitochondrial mem-
brane potentials [51]. We therefore investigated whether the
identified AID genes can also act through a process that guards
mitochondria against toxic insults. Rh123 imaging of uninfected
hippocampal neurons and hippocampal neurons infected with
rAAV-LacZ revealed the typical increase in Rh123 fluorescence
after application of NMDA (30 mM), which is indicative of the
break—down of mitochondrial membrane potential [2,51,52]. In
contrast, in hippocampal neurons that had been infected with
rAAV to express the AID genes Npas4, Inhibin b-A, Ifi202b, and
Nr4a1, or to express the previously identified neuroprotective gene,
Bcl6 [6], the NMDA-induced loss of mitochondrial membrane
potential occurred with slower kinetics and reached significantly
lower magnitudes (Figure 5A–5C). A quantitative analysis of the
imaging data revealed that expression of Npas4 and Bcl6 had the
largest inhibitory effects on the NMDA-induced break—down of
mitochondrial membrane potential (Figure 5B and 5C). The
inhibitions by Inhibin b-A, Ifi202b, and Nr4a1 were smaller but also
significant, whereas no significant reductions were observed for
Atf3, GADD45b, GADD45c, and Serpinb2 under the conditions used
(Figure 5B and 5C). These results suggest that one converging
point common to several AID genes is the mitochondria, which are
rendered more resistant against death signal-induced dysfunction.
Figure 5. Rh123 imaging of NMDA–induced break-down of mitochondrial membrane potential. (A) Rh123 imaging of uninfected
hippocampal neurons and hippocampal neurons infected with the indicated rAAVs. Neurons were stimulated with NMDA (30 mM) for 4 min followed
by washout of NMDA and treatment at the indicated time with the mitochondrial uncoupler, FCCP (5 mM) to obtain the maximal Rh123 signals.
Representative traces are shown; the thick line represents the mean value. (B,C) Quantitative analysis of Rh123 measurements. The NMDA-induced
percent increase in Rh123 fluorescence after NMDA application is shown in (B). The area under the curve represents the integral of the Rh123 signals
above baseline beginning at the time of NMDA application until the application of FCCP (C). Data represents mean6SEM (n$4 independent
experiments, with at least 100 single cells). Statistical analysis was determined by analysis of variance (ANOVA); *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pgen.1000604.g005
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death
We next analyzed the neuroprotective activity of AID genes in vivo.
Stereotaxic injection was used to deliver rAAVs carrying expression
cassettes for AID genes or appropriate negative controls (i.e. rAAV-
LacZ and rAAV-Empty) to the dorsal hippocampus of male Sprague-
Dawley rats weighing 230 to 250 g. We also included Ptgs2 in our in
vivo analysis as an additional negative control. Expression of Ptgs2 is
robustly induced by neuronal activity in a nuclear calcium/
CaMKIV dependent manner (Figure 2). However, there is no
available evidence for a role of Ptgs2 in promoting survival of
neuronal or non-neuronal cells and we therefore expected that
expression of Ptgs2 in vivo would not provide neuroprotection. Two
weeks after viral delivery, the rats were injected intra-peritoneally
with kainic acid (KA), which induces seizures leading to cell death in
the hippocampus [53]. The animals were sacrificed three days after
KA injection. The brains were removed, cut into slices, and stained
with the histofluorescent label, Fluoro-Jade C, which serves as a very
reliable marker for degenerating neurons [54]. The slices were
immunostained with antibodies to the neuronal marker, NeuN, and
antibodies to the Flag tag to detect the over-expressed proteins. We
found widespread KA-induced cell death in the CA1 region of the
hippocampus of animals injected with rAAV-Empty,r A A V - LacZ,
andrAAV-Ptgs2,aswellasintheCA1regionofthenon-injected side
of the hippocampus (Figure 6). In contrast, expression of AID genes
in the CA1 area of the injected side of the hippocampus protected
against KA-induced cell death (Figure 7). Quantification of the
Fluoro-Jade C signals revealed inhibitions of KA-induced cell death
of 8567% (Atf3), 8765% (Btg2), 9266% (GADD45b), 9362
(GADD45c), 9661% (Ifi202b), 7068% (Inhibin b-A), 9263% (Npas4),
9067% (Nr4a1), and 9661% (Serpinb2); over-expression of Ptgs2 or
LacZ did not inhibit KA-induced cell death (Table 2). Expression of
Btg2, Ifi202b,a n dSerpinb2 consistently led to neuroprotection also on
the contralateral (i.e. non-injected) side (Figure 7, Table 2). This
could be due to secretion of the neuroprotective protein, which may
be the case for the serine proteinase inhibitor, Serpinb2. It is also
conceivable that expression of neuroprotective proteins in the
processes of infected neurons, which project to the contralateral
hippocampus,canpromotesurvivaloftargetneuron;thismaybe the
case for flag-tagged Ifi202b which is readily detectable in the
hippocampus of the non-injected, contralateral side (see Figure 7).
Figure 6. Kainate-induced neuronal cell death in control groups. Kainate-induced cell death was assessed by Fluoro-Jade C labeling and
NeuN immunoreactivity in the CA1 region of the rat hippocampus. (A) Without systemic administration of kainate to rats that have been
stereotaxically injected unilaterally with PBS into the dorsal hippocampus, there was no Fluoro-Jade C staining in CA1 of the hippocampus of the
ipsilateral (i.e. injected) and the contralateral (i.e. the non-injected) hemispheres. (B–E) Robust Fluoro-Jade C staining in the CA1 pyramidal cell layer
was detected three days after systemic administration of kainate to rats that have been stereotaxically injected unilaterally into the dorsal
hippocampus with PBS (saline, B), rAAV-Empty (C), rAAV-LacZ (D), rAAV-Ptgs2 (E) two weeks prior to kainate treatment. The ipsilateral (i.e. injected)
hemispheres and the contralateral (i.e. the non-injected) hemispheres are shown. Viral vector-mediated expression of Flag-tagged Ptgs2 and LacZ
was detected using antibodies to the Flag tag. Neurons were labeled using the neuronal marker NeuN. Note the reduction in NeuN staining three
days after systemic administration of kainate indicating dramatic loss of neurons (compare NeuN immunoreactivity in (A) with that in (B) through (E)).
Representative examples are shown from (A, n=3; B, n=9; C, n=9; D, n=12; E, n=12). A quantitative analysis of the Fluoro-Jade C staining is given in
Table 2. Scale bar is 100 mm.
doi:10.1371/journal.pgen.1000604.g006
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Neuronal activity boosts neuroprotection. Our study has
identified the key players in this process. Using a strategy that
combined the identification of all genes controlled by neuronal
activity and nuclear calcium signaling with subsequent bioinfor-
matics filtering procedures, a set of genes was unearthed that
provides neurons with a robust neuroprotective shield. The core
Figure 7. AID genes provide neuroprotection in vivo. Analysis of kainate-induced cell death in CA1 hippocampal neurons over-expressing Flag-
tagged Atf3, Btg2, GADD45b, GADD45c, Ifi202b, Inhibin b-A, Npas4, Nr4a1, and Serpinb2. Degeneration of neurons and cell loss in the CA1 region of
the hippocampus was assessed using Fluoro-Jade C labeling and NeuN immunoreactivity three days after systemic administration of kainic acid to
rats that have been stereotaxically injected unilaterally into the dorsal hippocampus with rAAV-Atf3, rAAV-Btg2, rAAV-GADD45b, rAAV-GADD4c, rAAV-
Ifi202b, rAAV-Inhba, rAAV-Npas4, rAAV-Nr4a1, or rAAV-Serpinb2 two weeks prior to kainate treatment. The ipsilateral (i.e. injected) hemisphere and the
contralateral (i.e. the non-injected) hemisphere are shown. Viral vector-mediated expression of Flag-tagged Atf3, Btg2, GADD45b, GADD45c, Ifi202b,
Inhibin-bA, Npas4, Nr4a1, and Serpinb2 was detected using antibodies to the Flag tag. Note the decrease of Fluoro-Jade C labeling and the stronger
NeuN immunoreactivity on the ipsilateral (i.e. injected) hemisphere relative to the contralateral (i.e. the non-injected) hemisphere. In case of rAAV-
Ifi202b and rAAV-Serpinb2, Ifi202b and Serpinb2 were consistently expressed also in the hippocampus of the contralateral (i.e. the non-injected)
hemisphere and protected neurons from kainate-induced death. Representative examples are shown (n=12). A quantitative analysis of the Fluoro-
Jade C staining is given in Table 2. Scale bar is 100 mm.
doi:10.1371/journal.pgen.1000604.g007
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as AID genes.
Nuclear calcium: key player in the dialogue between
synapse and nucleus in neuronal survival
Activity-dependent, long-lasting neuroprotection as well as
other adaptive responses in the nervous system require the
dialogue between the synapse and the nucleus. There is growing
evidence to suggest that calcium signals propagating from their site
of activation at the plasma membrane towards the cell soma and
the nucleus are key mediators of synapse-to-nucleus communica-
tion. Nuclear calcium, most likely acting via nuclear calcium/
calmodulin dependent protein kinases, controls CREB/CBP-
dependent transcription [12,35,36,43–46] and is thought to
regulate genomic programs critical for neuronal survival, synaptic
plasticity, memory formation, and emotional behavior [3,6,55–
59]. In this study, we identified the nuclear calcium-regulated gene
pool in hippocampal neurons. The large number of 185 genes
induced or repressed by nuclear calcium signaling is not
unexpected. A genome-wide analysis revealed that CREB – the
principal target of nuclear calcium signaling - can occupy between
4000 and 6000 promoter sites in the rat or human genome,
although the transcription of only a subset of those genes is signal-
induced in a given cell type perhaps due to preferential
recruitment of CBP [39,40,60]. Indeed, 56% of nuclear calcium-
regulated genes and all AID genes except Npas4 are known or
putative CREB targets (Table S1), underscoring the importance of
the nuclear calcium-CREB axis in neuronal survival.
Possible common targets and end points of
neuroprotection
The AID genes characterized in this study fall into two functional
categories: regulators of gene transcription and secreted proteins.
Although they may act in concert to collectively provide full
neuroprotection, over-expression of individual AID genes is
sufficient to promote survival. Moreover, RNAi-based loss-of-
function experiments indicate that the selective reduction of
individual AID genes can compromise the activity-induced build-
up ofa neuroprotectiveshield. These results could be explained by a
possible convergence of AID genes on one or a small number of
targets that execute protection. Given that 7 out of 9 AID genes are
putative regulators of gene expression, the existence of common
target genes that arepart of a ‘secondwave’transcriptional response
is conceivable. Under physiological condition, a signal-regulated,
coordinate inductionoftransiently expressed genes maybe required
fortheregulationofcommontargets;thusinterferencewithoneora
small number of AID genes would disturb the system. However,
high-level, constitutive expression of individual AID genes may be
sufficient to activate or inactivate down-stream regulators of
survival. The regulation of a putative common target could involve
direct trans-activation by AID gene products through binding to the
target genes’ promoter elements, although other modes of
regulation (such as control of mRNA or protein stability or
activity-regulating post-translational modifications) are conceivable
and may involve secondary responses triggered by AID genes.
Additional components of such a regulatory network may include
other survival-promoting transcriptional regulators such as C/EBPb
[61–64], or the secreted AID genes Serpinb2 and Inhibin b-A,o rBdnf
[65] (see Table 1); these genes may contribute through transcrip-
tion-dependent and transcription-independent processes to the
funneling of information flow and the reduction of complexity to
few molecules implementing neuroprotection. Mitochondria, which
are vital for supplying the energy required to maintain life, may be
the end-point of neuroprotective processes. In this study we show
that expression of AID genes renders the mitochondria of
hippocampal neurons more resistant to harmful conditions. Thus,
neuroprotection may ultimately guard mitochondria against stress
and toxic insults to prevent mitochondrial dysfunction.
Table 2. Neuroprotective activities of AID genes in vivo.
Group Stereotaxic Kainate Injected Side Non-Injected Side
Injection FJC Signal (% Control) FJC Signal (% Control)
Control Saline 2 2.961.8 3.462.1
Saline + 100.1610.9 96.5615.6
rAAV-Empty + 126.0628.3 124.8622.8
rAAV-LacZ + 137.867.8 122.9615.0
rAAV-Ptgs2 + 127.3619.4 131.366.4
AID genes rAAV-Atf3 + 15.466.5 *** 86.467.2
rAAV-Btg2 + 13.165.3 *** 44.1611.6 **
rAAV-GADD45b + 8.166.2 *** 84.4615.3
rAAV-GADD45c + 7.562.1 *** 103.8621.5
rAAV-Ifi202b + 4.460.7 *** 5.760.7 ***
rAAV-Inhba + 30.067.7 *** 83.568.3
rAAV-Npas4 + 8.463.4 *** 97.0621.5
rAAV-Nr4a1 + 10.166.6 *** 113.3625.5
rAAV-Serpinb2 + 3.761.3 *** 4.560.5 ***
A quantitative analysis of the Fluoro-Jade C staining in the CA1 area of the hippocampus of non-injected and control-injected animals and animals stereotaxically
injected with rAAVs expressing AID genes. The Fluoro-Jade C signal obtained without and with kainate treatment in the hippocampus of both the injected and the non-
injected side is expressed as a percentage of control, i.e. the average kainate-induced Fluoro-Jade C signal obtained from the non-injected hemispheres of kainate
treated animals (for details see Methods). The mean6SEM is given; compared to control condition ‘saline plus kainate’, each AID gene significantly reduced the Fluoro-
Jade C signal (t-test; **p,0.01; ***p,0.001).
doi:10.1371/journal.pgen.1000604.t002
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unifying theme in neurodegenerative disorders and
aging
The finding that activation of synaptic NMDA receptors and
calcium signaling to the cell nucleus builds up a strong and lasting
neuroprotective shield may change our view of neurodegenerative
disorders and cell death associated with aging. Proper functioning
of the endogenous neuroprotective machinery requires a sequence
of events that can be disturbed at the level of synaptic
transmission, synaptic NMDA receptor activation, the generation
of calcium signal and their propagation to the cell nucleus, and the
regulation of gene transcription. Malfunctioning of calcium
signaling towards and within the cell nucleus may lead to
neurodegeneration and neuronal cell death. In Alzheimer’s disease
cell death may be caused by compromised endogenous neuropro-
tection due to impaired synaptic transmission and synapse loss
caused by A-b or changes in calcium homeostasis or calcium
signaling in neurons expressing mutant presenilin-1 [66–71].
Consistent with this concept is the observation that compared to
an age-matched healthy control group, individuals with Alzhei-
mer’s disease have reduced levels of the activated (i.e. phosphor-
ylated) form of CREB [72]; calcium signaling to the cell nucleus is
the key inducer of CREB phosphorylation on its activator site
serine 133 [12]. Similarly, in aged neurons, calcium signaling may
be altered at the level of calcium signal generation and/or calcium
signal propagation [73–75]. This could explain the reduced levels
of serine 133-phosphorylated CREB in the hippocampus of aged,
learning-impaired rats [76–78], which could lead to compromised
endogenous neuroprotection, progressive cell loss and cognitive
decline. The development of strategies to boost the endogenous
neuroprotective machinery may lead to effective therapies of
neurodegenerative condition. Both in disease and aging, health
and functionality of neurons may be preserved by expressing AID
genes or by restoring or enhancing key signals, in particular
nuclear calcium.
Methods
Hippocampal cultures and stimulations
Hippocampal neurons from newborn C57/Black mice were
cultured in Neurobasal media (Invitrogen, Carlsbad, CA, USA)
containing 1% rat serum, B27 (Invitrogen, Carlsbad, CA, USA),
and penicillin and streptomycin (Sigma). The procedure used to
isolate and culture hippocampal neurons has been described
[79,80]. The hippocampal cultures used for this study typically
contained about 10 to 15% glial cells and therefore a fraction of
the RNA isolated from the cultures was derived from glial cells.
Stimulations were done after a culturing period of 9 to 12 days
during which hippocampal neurons develop a rich network of
processes, express functional NMDA-type and AMPA/Kainate-
type glutamate receptors, and form synaptic contacts [12,81].
Action potential bursting was induced by treatment with the
GABAA receptor antagonist bicuculline (Sigma) (50 mM) as
described previously [2,11,12]. In the survival experiments,
neurons were treated for 16 hours with bicuculline in the presence
of 250 mM 4-amino pyridine (4-AP; Calbiochem) [2]. 4-AP
increases the frequency of the bicuculline-induced action poten-
tials bursts, thereby enhancing nuclear calcium, CREB-mediated
transcription, and activity-induced neuroprotection [2,11,12].
Whole-genome transcription profiling
DNA microarray analysis was done using Affymetrix GeneChip
Mouse Genome 430 2.0 Arrays. See Text S1 for details.
Recombinant adeno-associated virus (rAAV) and viral
infections
The vectors used to construct and package rAAVs have been
described previously [6]. The rAAV cassette for mRNA expression
contains a CMV/chicken b actin hybrid promoter. The following
rAAVs were generated and confirmed by DNA sequencing:
rAAV-Atf3, rAAV-CaMKIVK75E, rAAV-GADD45b, rAAV-
GADD45c, rAAV-Ifi202b, rAAV-Inhba, rAAV-LacZ, rAAV-Npas4,
rAAV-Nr4a1, rAAV-Ptgs2, and rAAV-Serpinb2. rAAV-Btg2 and
rAAV-CaMBP4 have been described [6]. All rAAV-expressed
proteins except hrGFP carry a Flag tag. For shRNA expression, a
rAAV vector was used that contains the U6 promoter for shRNA
expression and a CMV/chicken b actin hybrid promoter driving
hrGFP expression [6]. For details on the construction of rAAVs
expressing shRNAs see Text S1. Hippocampal neurons were
infected with rAAVs at 4 days in vitro (DIV). Infection efficiencies
were routinely determined immunocytochemically at 9 DIV or 10
DIV using antibodies to the Flag tag or to hrGFP or by analyzing
the fluorescence of hrGFP; they ranged from 80 to 95 percent of
the viable neurons [6].
Quantitative reverse transcriptase PCR (QRT–PCR)
To determine the mRNA expression levels of Atf3, GADD45b,
GADD45c, Ifi202b, Inhba, Npas4, Nr4a1, Ptgs2, Serpinb2, Gusb, and
glyceraldehyde-3-phosphate dehydrogenase (Gapdh), QRT-PCR
was performed using real-time TaqMan technology with a
sequence detection system model 7300 Real Time PCR System
(Applied Biosystems, Foster City, California, USA). For further
details, see Text S1.
Assessment of cell death in hippocampal cultures
As described previously [2,3], two types of assays were used to
investigate apoptotic cell death and the protection from cell death
afforded by a period of action potential bursting. At 10 DIV,
activity-dependent survival was induced by treatment of the
neurons for 16 hours with bicuculline (50 mM) and 4-AP
(250 mM). All electrical activity of the network was subsequently
stopped using tetrodotoxin (TTX; TOCRIS Bioscience) (1 mM)
followed by keeping the cells either in regular medium (containing
growth and trophic factors) with or without staurosporine
(Calbiochem) (10 nM), or in medium lacking growth and trophic
factors, all in the presence of TTX (1 mM). The principal growth
and trophic factors in the regular, serum-free hippocampal
medium [termed transfection medium (TM) [76]] are insulin,
transferrin, and selenium. Staurosporine-induced and growth
factor withdrawal-induced apoptosis was assessed after 36 hours
and 72 hours, respectively, by determining the percentage of
hippocampal neurons with shrunken cell body and large round
chromatin clumps characteristic of apoptotic death [2,3]. In the
growth factor withdrawal assays, basal cell death is slightly higher
due to the differences in the time that the neurons are kept in
serum free, TTX-containing media. At least 20 visual fields from
each coverslip (corresponding to 1500–2000 cells per coverslip)
were counted with Hoechst 33258 (Serva) and the percentage of
dead cells was determined. TUNEL assays (Roche, Mannheim,
Germany) were done according the instructions provided by the
manufacturer and were used to validate the analysis of cell death
using the Hoechst 33258 stain. Photomicrographs of examples of
healthy and apoptotic hippocampal neurons stained with TUNEL
and with Hoechst 33258 are shown in Figure S1. All cell death
analyses were done without knowledge of the treatment history of
the cultures. All results are given as means6SEM; statistical
significance was determined by ANOVA.
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Imaging of mitochondrial membrane potential was done using
Rhodamine 123 (Rh123; Molecular Probes, Eugene, OR) as
described [2,51,52]. Imaging and data analysis were performed
without knowing the experimental conditions. Quantitative
measurements are given as means6SEM from n$4 experiments,
with at least 100 cells analyzed each. Statistical significance was
determined by ANOVA.
Stereotaxic injections
rAAVs were delivered by stereotaxic injection into the dorsal
hippocampus of male Sprague-Dawley rats weighing 230–250 g.
Rats were randomly grouped and anaesthetized with ketamine. A
total volume of 3 ml containing 3610
8 genomic virus particles
were injected unilaterally over a period of 30 min at the following
coordinates relative to Bregma: anteroposterior, 23.8 mm;
mediolateral, 2.8 mm; dorsoventral, 22.8 to 23.8 mm from the
skull surface. Procedures were done in accordance with German
guidelines for the care and use of laboratory animals and to the
respective European Community Council Directive 86/609/EEC.
Kainate-induced status seizures
Two weeks after rAAV delivery, rats were injected with kainate
(Sigma; 10 mg/kg i.p.) or vehicle (phosphate-buffered saline, PBS),
and monitored for at least 4 hours to categorize the severity of
epileptic seizures according to following criteria: level 1,
immobility; level 2, forelimb and/or tail extension, rigid posture;
level 3, repetitive movements, head bobbing; level 4, rearing and
falling; level 5, continuous rearing and falling; level 6, severe tonic-
clonic seizure [82]. Only animals that exhibited at least level 4 or 5
of epileptic seizure behavior were analyzed further. Three days
after seizure induction, animals were deeply anesthetized with an
overdose of Nembutal (300 mg/kg), pre-perfused transcardially
with PBS, and perfused with 200 ml of neutral phosphate buffered
10% formalin (Sigma). Brains were removed and post-fixed
overnight in the same fixative solution. For cryoprotection, brains
were incubated in 30% sucrose in PBS for 2 days. Brains were
rapidly frozen on dry ice. Frozen sections (40 mm thick) were
collected in PBS. Three consecutive sections separated by a
240 mm distance were used for immunostaining and Fluoro-Jade
C staining (Histo-Chem, Inc., Jefferson, Arkansas, USA), which
selectively stains degenerating neuronal cell bodies and processes,
regardless of the mechanism of cell death. Transgene expression
was detected with anti-Flag antibodies (1:2500, M2 mouse
monoclonal; Sigma). Neuronal cell loss was assessed with NeuN
immunostaining (1:500, mouse monoclonal; Chemicon). Immu-
nostaining was done using standard procedures. Fluoro-Jade C
staining was done as described previously [54]. Images of Fluoro-
Jade C staining were taken and the signals in the CA1 area of the
hippocampus were quantified. The quantification was performed
without knowing the experimental conditions. Images (106
objective, 1600*1200 pixels) of Fluoro-Jade C stained sections
were taken at central CA1 region infected with rAAVs. Sections
were collected every 240 mm by cryostat sectioning at the level of
3.0,5.0 mm posterior to Bregma. Five sections from each brain
hemisphere were chosen for image analysis. Fluoro-Jade C signals
from the images were quantified with NIH ImageJ software
(National Institute of Health, Bethesda, MD, USA). Background
intensity was measured from the CA1 area lacking positively-
stained neuronal cell bodies. Threshold level was set as means of
the background +3 SD. The CA1 pyramidal cell layer was
encircled manually and particle analysis was performed. Particles
were defined as 30 pixels to infinity, roundness 0,1.0. Total pixel
of Fluoro-Jade C positive particles from each section was obtained
to calculate the mean cell death area for each hemisphere. All
pixel values were normalized to the average kainate-induced
Fluoro-Jade C signal from the control (i.e. non-injected)
hemispheres of kainic acid treated animals; the signal obtained
from the non-injected hemispheres of the animals injected with
rAAV-Btg2, rAAV-Ifi202b, and rAAV-Serpinb2 was not included
into the calculation of the average kainate-induced Fluoro-Jade C
signal because for rAAV-Btg2, rAAV-Ifi202b, and rAAV-Serpinb2
we observed neuroprotection on the contralateral, non-injected
hemispheres.
Animals
All animal experiments were done in accordance with the
international ethical guidelines for the care and use of laboratory
animals and were approved by the local animal care committee of
the Regierungspra ¨sidium Karlsruhe. We minimized the number of
animals used and their suffering.
Supporting Information
Figure S1 Detection of dead hippocampal neurons using
Hoechst 33258 staining and TUNEL staining. TUNEL-positive
neurons were detected with the In Situ Cell Death Detection Kit
(TMR red) as described by the manufacturer (Roche, Mannheim,
Germany). Fluorescence images were acquired using a Leica SP2
confocal microscope. (A) Photomicrographs (low magnification) of
confocal microscopy images of hippocampal neurons stained with
Hoechst 33258 or with TUNEL stained. Neurons were exposed
for 24 hours to 20 nM of staurosporine (‘Death-Inducing-
Stimulus’) or were left untreated (‘No Treatment’). Scale bar is
20 mm. (B,C) Photomicrographs (high magnification) of confocal
microscopy images of individual hippocampal neurons stained
with Hoechst 33258 and with TUNEL. Representative examples
of healthy, TUNEL-negative (B) and apoptotic, TUNEL-positive
(C) neurons are shown. The pictures in (C) illustrate the broad
spectrum of the characteristic morphological changes associated
with apoptosis, which are readily identifiable using Hoechst 33258
staining. Scale bars, 10 mm.
Found at: doi:10.1371/journal.pgen.1000604.s001 (4.01 MB TIF)
Table S1 Nuclear calcium-regulated genes as putative CREB
targets. * see Zhang et al., Proc Natl Acad Sci U S A 102: 4459–
4464 and http://natural.salk.edu/creb/. * * see Impey et al., Cell
119: 1041–1054 and http://saco.ohsu.edu/.
Found at: doi:10.1371/journal.pgen.1000604.s002 (0.44 MB PDF)
Text S1 Supplemental Methods.
Found at: doi:10.1371/journal.pgen.1000604.s003 (0.05 MB
DOC)
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